lncRNA SOX2OT在胃癌中的表达及其与预后的关系-东南大学学报医学版

lncRNA SOX2OT在胃癌中的表达及其与预后的关系

单位：遂宁市中心医院胃肠外科, 四川遂宁 629000

分类号：735.2

出版年·卷·期（页码）：2023·42·第二期（278-283）

摘要：

目的:通过检测长链非编码RNA SOX2重叠转录本(lncRNA SOX2OT)在胃癌组织中的表达,分析lncRNA SOX2OT与胃癌患者预后的关系。方法:以本院诊治的105例胃癌患者为研究对象,术中收集癌组织及癌旁正常胃黏膜,采用实时荧光定量逆转录聚合酶链反应(qRT-PCR)检测组织中lncRNA SOX2OT表达水平。记录患者临床资料并随访3年,分析lncRNA SOX2OT表达水平与临床病理特征的关系。采用Kaplan-Meier法及Log rank检验分析胃癌组织lncRNA SOX2OT表达与患者生存率的关系。采用Cox回归模型分析胃癌患者预后的危险因素。结果:胃癌组织中lncRNA SOX2OT表达水平高于癌旁组织(3.49±0.57 vs. 1.16±0.32, P<0.05)。lncRNA SOX2OT表达与年龄、性别、饮酒、肿瘤位置、吸烟无关(P>0.05),与TNM分期、肿瘤直径、淋巴结转移及分化程度有关(P<0.05)。生存分析显示,lncRNA SOX2OT低表达组3年生存率比高表达组高(75.51% vs. 55.35%,Log rank χ²=4.451,P=0.031)。Cox多因素分析证实,低分化胃癌、Ⅲ~Ⅳ期、lncRNA SOX2OT高表达是影响胃癌患者预后的危险因素(P<0.05)。结论:胃癌组织中lncRNA SOX2OT表达上调,可能参与胃癌进展,是影响胃癌预后的危险因素。

Objective: To discuss the expression of long non-coding RNA SOX2 overlapping transcripts(lncRNA SOX2OT) in gastric cancer tissues and its relationship with prognosis. Methods: A total of 105 gastric cancer patients diagnosed and treated in our hospital were selected as the research objects. During the operation, the cancer tissues and the normal gastric mucosa adjacent to the cancer were collected, and the expression level of lncRNA SOX2OT in the tissues was detected by quantitative reverse transcription-polymerase chain reaction(qRT-PCR). The clinical data of the patients were recorded and the patients were followed up for 3 years. The relationship between the expression level of lncRNA SOX2OT and the clinicopathological characteristics was analyzed. Kaplan-Meier method and Log rank test were used to analyze the relationship between the expression of lncRNA SOX2OT in gastric cancer and the survival rate of patients. Cox regression model was used to analyze the risk factors for the prognosis of gastric cancer patients. Results: The expression level of lncRNA SOX2OT in cancer tissues was significantly higher than that in adjacent tissues(3.49±0.57 vs. 1.16±0.32), and the difference was statistically significant(P<0.05). The expression of lncRNA SOX2OT was not related to age, gender, drinking ratio, tumor location and smoking(P>0.05), but was related to TNM stage, tumor diameter, lymph node metastasis and degree of differentiation(P<0.05). Survival analysis showed that the 3-year survival rate of lncRNA SOX2OT low expression group was higher than that of higher expression group(75.51% vs. 55.35%, Log rank χ²=4.451, P=0.031). Cox multivariate analysis confirmed that poorly differentiated gastric cancer, stage Ⅲ-Ⅳ, and high expression of lncRNA SOX2OT were risk factors affecting the prognosis of gastric cancer patients(P<0.05). Conclusion: The expression of lncRNA SOX2OT is up-regulated in gastric cancer tissue, which may be involved in gastric cancer progression.

参考文献：

[1] JIANG D,SHU C,ZHANG W,et al.Low level of microsatellite instability correlates with short disease-free survival of gastric cancer patients undergoing neoadjuvant chemotherapy[J].Virchows Arch,2021,478(2):231-240.
[2] WANG X,LI S,SUN Y,et al.The protocol of a prospective,multicenter,randomized,controlled phase Ⅲ study evaluating different cycles of oxaliplatin combined with S-1(SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer:RESONANCE-II trial[J].BMC Cancer,2021,21(1):1-8.
[3] 薛春霞,李春美,李超,等.胃癌组织中长链非编码RNA ZDHHC8P1的水平及临床意义[J].临床肿瘤学杂志,2019,24(6):528-532.
[4] 李正龙,徐艺,冷开明,等.长链非编码RNA SOX2OT在肿瘤中的调控作用及对预后的影响[J].现代肿瘤医学,2018,26(14):2290-2293.
[5] NI J,ZHANG X,LI J,et al.Tumour-derived exosomal lncRNA-SOX2OT promotes bone metastasis of non-small cell lung cancer by targeting the miRNA-194-5p/RAC1 signalling axis in osteoclasts[J].Cell Death Dis,2021,12(7):1-10.
[6] 韩玲,张蔚.卵巢癌组织及细胞系长链非编码RNA SOX2OT表达临床意义研究[J].中华肿瘤防治杂志,2019,26(2):100-117.
[7] LIU B,ZHOU J,WANG C,et al.LncRNA SOX2OT promotes temozolomide resistance by elevating SOX2 expression via ALKBH5-mediated epigenetic regulation in glioblastoma[J].Cell Death Dis,2020,11(5):1-18.
[8] 国家卫生健康委员会.胃癌诊疗规范(2018年版)[J].中华消化病与影像杂志(电子版),2019,9(3):118-144.
[9] WASHINGTON K.7th edition of the AJCC cancer staging manual:stomach[J].Ann Surg Oncol,2010,17(12):3077-3079.
[10] SHEN Y,YU X,RUAN Y,et al.Global profile of tRNA-derived small RNAs in gastric cancer patient plasma and identification of tRF-33-P4R8YP9LON4VDP as a new tumor suppressor[J].Int J Med Sci,2021,18(7):1570-1579.
[11] 王佩,曹田宇,周云,等.FOXJ2转录激活胃癌细胞PD-L1表达并抑制T细胞抗肿瘤免疫的研究[J].中国肿瘤,2021,30(12):933-941.
[12] 朱佳丽,周永宁,袁文臻,等.奥沙利铂联合替吉奥与奥沙利铂联合卡培他滨用于胃癌新辅助化疗后不良反应的比较[J].中国药物警戒,2020,17(1):17-22.
[13] CHEN Y H,XIAO J,CHEN X J,et al.Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer[J].World J Gastroenterol,2020,26(19):2427-2439.
[14] 朱晓东,陈思元.不可或缺,还是无足轻重——胃癌新辅助化疗争议的探讨[J].复旦学报(医学版),2021,48(4):427-434.
[15] 丛雨欣,张秋菊,田伟,等.基于lncRNA-mRNA共表达网络筛选胃癌分期相lncRNA[J].中国卫生统计,2021,38(5):665-669.
[16] FENG Y,XU Y,GAO Y,et al.A novel lncRNA SOX2OT promotes the malignancy of human colorectal cancer by interacting with miR-194-5p/SOX5 axis[J].Cell Death Dis,2021,12(5):1-12.
[17] 郭飘婷,邹阳.LncRNA SOX2OT海绵吸附miR-34a促进SOX2表达增强大肠癌多药耐药[J].实用肿瘤学杂志,2020,34(5):398-403.
[18] 韩玲,张蔚.卵巢癌组织及细胞系长链非编码RNA SOX2OT表达临床意义研究[J].中华肿瘤防治杂志,2019,26(2):100-117
[19] 帅蓉,周媛,罗迪贤.长链非编码RNA在肺癌诊断治疗中的研究进展[J].山东医药,2020,60(5):99-102.
[20] ZHAN Y,CHEN Z,HE S,et al.Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2[J].Mol Cancer,2020,19(1):1-13.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录